1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Vestibular Diseases Global Clinical Trials Review, H2, 2015

Vestibular Diseases Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Vestibular Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Vestibular Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Vestibular Diseases. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Vestibular Diseases Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vestibular Diseases 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Vestibular Diseases 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Vestibular Diseases Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Sensorion S.A. 31
Clinical Trial Overview of Sensorion S.A. 31
SK Chemicals Co., Ltd. 32
Clinical Trial Overview of SK Chemicals Co., Ltd. 32
Neocutis, Inc. 33
Clinical Trial Overview of Neocutis, Inc. 33
Laboratoires Pierre Fabre SA 34
Clinical Trial Overview of Laboratoires Pierre Fabre SA 34
Fuerza Aerea de Chile 35
Clinical Trial Overview of Fuerza Aerea de Chile 35
Apsen Farmaceutica SA 36
Clinical Trial Overview of Apsen Farmaceutica SA 36
Clinical Trial Overview of Top Institutes / Government 37
Asan Medical Center 37
Clinical Trial Overview of Asan Medical Center 37
Centre Hospitalier Universitaire de Caen 38
Clinical Trial Overview of Centre Hospitalier Universitaire de Caen 38
Federal University of Sao Paulo 39
Clinical Trial Overview of Federal University of Sao Paulo 39
Hospital do Servidor Publico Estadual 40
Clinical Trial Overview of Hospital do Servidor Publico Estadual 40
Ludwig Maximilians Universitat Munich 41
Clinical Trial Overview of Ludwig Maximilians Universitat Munich 41
McGill University Health Center 42
Clinical Trial Overview of McGill University Health Center 42
Norwegian University of Science and Technology 43
Clinical Trial Overview of Norwegian University of Science and Technology 43
Schepens Eye Research Institute 44
Clinical Trial Overview of Schepens Eye Research Institute 44
Universite de Montreal 45
Clinical Trial Overview of Universite de Montreal 45
University Health Network 46
Clinical Trial Overview of University Health Network 46
Five Key Clinical Profiles 47
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68

List of Tables
Vestibular Diseases Therapeutics, Global, Clinical Trials by Region, 2015* 7
Vestibular Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vestibular Diseases Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Vestibular Diseases Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Vestibular Diseases Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Vestibular Diseases Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Vestibular Diseases Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15
Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18
Vestibular Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Vestibular Diseases Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Vestibular Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Vestibular Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Vestibular Diseases Therapeutics, Global, Withdrawn Clinical Trials, 2015* 24
Vestibular Diseases Therapeutics, Global, Terminated Clinical Trials, 2015* 25
Vestibular Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Vestibular Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Vestibular Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Vestibular Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Vestibular Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Sensorion S.A., 2015* 31
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Chemicals Co., Ltd., 2015* 32
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Neocutis, Inc., 2015* 33
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Pierre Fabre SA, 2015* 34
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Fuerza Aerea de Chile, 2015* 35
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Apsen Farmaceutica SA, 2015* 36
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 37
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Caen, 2015* 38
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 39
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital do Servidor Publico Estadual, 2015* 40
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig Maximilians Universitat Munich, 2015* 41
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University Health Center, 2015* 42
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2015* 43
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Schepens Eye Research Institute, 2015* 44
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite de Montreal, 2015* 45
Vestibular Diseases Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 46

List of Figures
Vestibular Diseases Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Vestibular Diseases Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Vestibular Diseases Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Vestibular Diseases Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Vestibular Diseases Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 15
Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Vestibular Diseases Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Vestibular Diseases to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 18
Vestibular Diseases Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 19
Vestibular Diseases Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Vestibular Diseases Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Vestibular Diseases Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Vestibular Diseases Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Vestibular Diseases Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Vestibular Diseases Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Vestibular Diseases Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Vestibular Diseases Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Vestibular Diseases Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 66

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.